Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 5
2009 2
2010 2
2011 6
2012 1
2013 2
2014 4
2015 5
2016 2
2017 1
2018 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.
Elbaz M, Nasser MW, Ravi J, Wani NA, Ahirwar DK, Zhao H, Oghumu S, Satoskar AR, Shilo K, Carson WE 3rd, Ganju RK. Elbaz M, et al. Mol Oncol. 2015 Apr;9(4):906-19. doi: 10.1016/j.molonc.2014.12.010. Epub 2015 Jan 19. Mol Oncol. 2015. PMID: 25660577 Free PMC article.
Non-contact method for directing electrotaxis.
Ahirwar DK, Nasser MW, Jones TH, Sequin EK, West JD, Henthorne TL, Javor J, Kaushik AM, Ganju RK, Subramaniam VV. Ahirwar DK, et al. Sci Rep. 2015 Jun 9;5:11005. doi: 10.1038/srep11005. Sci Rep. 2015. PMID: 26055698 Free PMC article.
Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
Charan M, Das S, Mishra S, Chatterjee N, Varikuti S, Kaul K, Misri S, Ahirwar DK, Satoskar AR, Ganju RK. Charan M, et al. Cell Death Dis. 2020 Sep 17;11(9):774. doi: 10.1038/s41419-020-02992-y. Cell Death Dis. 2020. PMID: 32943608 Free PMC article.
Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation.
Ahirwar DK, Nasser MW, Ouseph MM, Elbaz M, CuitiƱo MC, Kladney RD, Varikuti S, Kaul K, Satoskar AR, Ramaswamy B, Zhang X, Ostrowski MC, Leone G, Ganju RK. Ahirwar DK, et al. Oncogene. 2018 Aug;37(32):4428-4442. doi: 10.1038/s41388-018-0263-7. Epub 2018 May 3. Oncogene. 2018. PMID: 29720724 Free PMC article.
miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
Zhao H, Wilkie T, Deol Y, Sneh A, Ganju A, Basree M, Nasser MW, Ganju RK. Zhao H, et al. Mol Cancer. 2015 Jan 27;14:11. doi: 10.1186/s12943-014-0275-z. Mol Cancer. 2015. PMID: 25622979 Free PMC article.
CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis.
Lu Y, Wu Y, Feng X, Shen R, Wang JH, Fallahi M, Li W, Yang C, Hankey W, Zhao W, Ganju RK, Li MO, Cleveland JL, Zou X. Lu Y, et al. J Clin Invest. 2014 Apr;124(4):1672-84. doi: 10.1172/JCI63139. Epub 2014 Mar 10. J Clin Invest. 2014. PMID: 24614102 Free PMC article.
Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.
Elbaz M, Ahirwar D, Ravi J, Nasser MW, Ganju RK. Elbaz M, et al. Oncotarget. 2017 May 2;8(18):29668-29678. doi: 10.18632/oncotarget.9408. Oncotarget. 2017. PMID: 27213582 Free PMC article.
Endothelial Robo4 suppresses breast cancer growth and metastasis through regulation of tumor angiogenesis.
Zhao H, Ahirwar DK, Oghumu S, Wilkie T, Powell CA, Nasser MW, Satoskar AR, Li DY, Ganju RK. Zhao H, et al. Mol Oncol. 2016 Feb;10(2):272-81. doi: 10.1016/j.molonc.2015.10.007. Epub 2015 Oct 28. Mol Oncol. 2016. PMID: 26778715 Free PMC article.
RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment.
Nasser MW, Wani NA, Ahirwar DK, Powell CA, Ravi J, Elbaz M, Zhao H, Padilla L, Zhang X, Shilo K, Ostrowski M, Shapiro C, Carson WE 3rd, Ganju RK. Nasser MW, et al. Cancer Res. 2015 Mar 15;75(6):974-85. doi: 10.1158/0008-5472.CAN-14-2161. Epub 2015 Jan 8. Cancer Res. 2015. PMID: 25572331 Free PMC article.
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer.
Elbaz M, Ahirwar D, Xiaoli Z, Zhou X, Lustberg M, Nasser MW, Shilo K, Ganju RK. Elbaz M, et al. Oncotarget. 2016 May 27;9(71):33459-33470. doi: 10.18632/oncotarget.9663. eCollection 2018 Sep 11. Oncotarget. 2016. PMID: 30323891 Free PMC article.
29 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback